Overview

Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)

Status:
Not yet recruiting
Trial end date:
2024-02-28
Target enrollment:
Participant gender:
Summary
The current guideline recommends to give antithrombotic treatment 24 hours after intravenous thrombolysis in acute ischemic stroke. However, early neurological deterioration will occur in some patients due to no antithrombotic treatment, which is closely associated with poor outcome. The current trial aims to investigate the effectiveness and safety of early antithrombotic treatment after intravenous thrombolysis in minor stroke.
Phase:
Phase 4
Details
Lead Sponsor:
General Hospital of Shenyang Military Region
Treatments:
Aspirin
Clopidogrel